Related Experiment Video

Updated: Sep 14, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Gab1, SHP-2 and other novel regulators of Ras: targets for anticancer drug discovery?

Armelle Yart1, Patrick Mayeux, Patrick Raynal

  • 1INSERM U563, Centre de Physiopathologie de Toulouse-Purpan, Dept. of Lipoproteins and Lipid Mediators, I.F.R.30, Hôpital Purpan, 31059 Toulouse, France.

Current Cancer Drug Targets
|May 29, 2003
PubMed

Insights

Ras proteins are key molecular switches in cell signaling. Targeting novel effectors like Gab1 in Ras pathways offers potential for new cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Ras proteins act as molecular switches, cycling between GDP-bound (inactive) and GTP-bound (active) states.
  • GTP-locked Ras mutants and wild-type Ras signaling are crucial in human tumor development by integrating proliferative and anti-apoptotic signals.
  • Protein tyrosine kinases and other oncogenic molecules utilize Ras to relay transforming potential.

Purpose of the Study:

  • To review recent advancements in understanding the role of Gab1 and its associated proteins in Ras activation.
  • To explore the involvement of these novel effectors in cell proliferation and survival pathways.
  • To discuss the implications for targeting these pathways in cancer pharmacotherapy.

Main Methods:

  • Review of recent genetic and molecular studies on Ras signaling pathways.
  • Analysis of the literature on Gab1, SHP-2, and phosphoinositide 3-kinase interactions.
  • Discussion of pharmacological strategies targeting Ras pathway components.

Main Results:

  • Novel effectors, including Gab1, SHP-2, and phosphoinositide 3-kinase, participate in Ras activation beyond the canonical Shc/Grb2/Sos module.
  • These proteins are critically involved in regulating cell proliferation and survival.
  • Genetic evidence supports their significant role in oncogenesis.

Conclusions:

  • Gab1 and its partners are integral to Ras-mediated cell growth and survival signaling.
  • These molecules represent promising therapeutic targets for selective cancer treatment.
  • Pharmacological manipulation of this pathway holds potential for novel anti-tumoral strategies.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: